カテゴリー： 世界, 医療/バイオ, Research Dive

世界の気道管理デバイス市場2022年-2031年：デバイス種類別（声門下デバイス、声門上デバイス、喉頭鏡、蘇生器、その他）、患者年齢別（成人患者、小児患者）、エンドユーザー別（病院、外来治療、在宅ケア、その他）

【英語タイトル】Airway Management Devices Market by Device Type (Infraglottic Devices, Supraglottic Devices, Laryngoscopes, Resuscitators, and Others), Patient Age (Adult Patients and Pediatric Patients), and End User (Hospitals, Ambulatory Care, Home Care, and Others): Global Opportunity Analysis and Industry Forecast 2022–2031

Research Diveが出版した調査資料（RDV23MA012）・商品コード：RDV23MA012
・発行会社（調査会社）：Research Dive
・発行日：2022年12月13日
・ページ数：250
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：生命科学
◆販売価格オプション（消費税別）
Single UserUSD5,700 ⇒換算￥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算￥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算￥1,626,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Research Dive社の本調査レポートでは、世界の気道管理デバイス市場規模が2021年1,961.50百万ドルから2031年には4,182.20ドルに達し、年平均7.7%成長すると予測しています。本レポートは、気道管理デバイスの世界市場について調査を行い、調査手法、調査範囲、エグゼクティブサマリー、市場概要、デバイス種類別（声門下デバイス、声門上デバイス、喉頭鏡、蘇生器、その他）分析、患者年齢別（成人患者、小児患者）分析、エンドユーザー別（病院、外来治療、在宅ケア、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況などの項目をまとめています。なお、企業情報には、Medtronic, Smiths Medical, Inc., Teleflex Incorporated., KARL STORZ SE & Co. KG, Ambu A/S., Flexicare (Group) Limited, Intersurgical Ltd, SunMed, VYAIRE MEDICAL, INC., and Vbm Medizintechnik.などが含まれています。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界の気道管理デバイス市場規模：デバイス種類別
- 声門下デバイスの市場規模
- 声門上デバイスの市場規模
- 喉頭鏡の市場規模
- 蘇生器の市場規模
- その他デバイスの市場規模
・世界の気道管理デバイス市場規模：患者年齢別
- 成人患者における市場規模
- 小児患者における市場規模
・世界の気道管理デバイス市場規模：エンドユーザー別
- 病院における市場規模
- 外来治療における市場規模
- 在宅ケアにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の気道管理デバイス市場規模：地域別
- 北米の気道管理デバイス市場規模
- ヨーロッパの気道管理デバイス市場規模
- アジア太平洋の気道管理デバイス市場規模
- 中南米の気道管理デバイス市場規模
- 中東/アフリカの気道管理デバイス市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global airway management devices market is anticipated to generate a revenue of $4,182.20 million by 2031, increasing from $1,961.50 million in 2021, at a CAGR of 7.7%.

COVID-19 Impact on the Global Airway Management Devices Market:
COVID-19 has positively impacted various industries such as the medical sector that has led to a drastic increase in medicines sales. As airway management devices are widely used to alleviate upper airway obstruction caused by tonsillar or adenoidal hypertrophy, or normal pharyngeal tissue obstruction, there was a significant rise in the airway management device demand globally. The COVID-19 pandemic has caused a spike in the number of patients being admitted to ICUs and emergency rooms. Patients with severe infections frequently need ventilators and other positive air pressure devices to treat respiratory failure or low oxygen saturation. Therefore, there is a higher need for airway management devices, particularly single-use ones. The number of patients who require intubation using invasive airway management techniques has increased due to the possibility of virus particles being aerosolized during non-invasive procedures. The market for airway management devices has expanded owing to the high risk faced by healthcare professionals providing airway management treatment to COVID-19 patients and other patients throughout healthcare institutions.

Various initiatives taken by companies to support airway management device projects are helping society to recover from the pandemic. For instance, on January 6, 2022, ICU Medical Inc. (NASDAQ: ICUI) announced that it has completed its acquisition of Smiths Medical from Smiths Group plc (LSE: SMIN.L). The Smiths Medical business includes a syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the acquired companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately $2.5 billion.

Airway Management Devices Market Analysis:
The market has also been impacted by the increase in funds provided by the federal government to promote the adoption of airway management medical devices. The market for airway management devices also benefits from the rise in healthcare spending, improvements in the healthcare infrastructure, and a strong need for extended care delivery. Furthermore, airway difficulties in patients with cardiac, infectious, or chronic illnesses typically require prompt medical attention. A fast airway clearance may also be necessary to protect the safety of victims of car accidents or other traumatic injuries. The demand for airway management devices is rising globally owing to the increase in the prevalence of chronic respiratory diseases.
As the number of airway management devices increases, airway management is expected to become more complicated and limited due to factors such as intubation and others. Although endotracheal intubation is one of the most often used methods, employing it comes with risks and difficulties. Most underdeveloped countries have low adoption rates for pricey airway management devices due to their ineffective reimbursement policies or lack of public health insurance. All these factors are anticipated to restrain the airway management devices market demand during the forecast period.
Patients with COVID-19 who need ventilation are frequently intubated using single-use tracheostomy or endotracheal tubes. The market for airway management devices has increased globally as a result of the rise in the prevalence of COVID-19. Furthermore, technological advances are also encouraging major players to seek strategic agreements in order to grow quickly. This is projected to expand the market for airway management devices in the future. All these aspects are predicted to boost the airway management devices market size in the upcoming years.

Based on devices type, the infraglottic devices sub-segment is predicted to show the fastest growth rate by 2031. A small incision is made at the base of the glottis in the trachea and an infra-glottic airway device is introduced into it for ventilation and airway management. Tracheostomy tubes and endotracheal tubes are two further divisions of infraglottic devices.
Based on patient age, the adult patients sub-segment accounted for the most dominant sub-segment in 2021. The main drivers of the adult patients segment include the increase in the aging population and the rise in chronic diseases in elderly patients.
Based on end user, the hospitals sub-segment accounted for the most dominant sub-segment in 2021, due to the growing use of airway management devices in the healthcare industry.
Based on geographical scope, the Asia-Pacific airway management devices market is anticipated to show the fastest growth by 2031. The regional airway management market is expected to witness the quickest growth due to an increase in public knowledge of technology breakthroughs and airway management applications.
The companies involved in the global airway management devices market are Medtronic, Smiths Medical, Inc., Teleflex Incorporated., KARL STORZ SE & Co. KG, Ambu A/S., Flexicare (Group) Limited, Intersurgical Ltd, SunMed, VYAIRE MEDICAL, INC., and Vbm Medizintechnik.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on Global Airway Management Devices market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental

4.7.Impact of COVID-19 on Airway Management Devices market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.Airway Management Devices Market Analysis, by Device Type

5.1.Overview
5.2.Infraglottic Devices

5.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.2.2.Market size analysis, by region, 2021-2031
5.2.3.Market share analysis, by country, 2021-2031

5.3.Supraglottic Devices

5.3.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.3.2.Market size analysis, by region, 2021-2031
5.3.3.Market share analysis, by country, 2021-2031

5.4.Laryngoscopes

5.4.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.4.2.Market size analysis, by region, 2021-2031
5.4.3.Market share analysis, by country, 2021-2031

5.5.Resuscitators

5.5.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.5.2.Market size analysis, by region, 2021-2031
5.5.3.Market share analysis, by country, 2021-2031

5.6.others

5.6.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.6.2.Market size analysis, by region, 2021-2031
5.6.3.Market share analysis, by country, 2021-2031

5.7.Research Dive Exclusive Insights

5.7.1.Market attractiveness, 2021-2031
5.7.2.Competition heatmap, 2021-2031

6.Airway Management Devices Market, by Patient Age

6.1.Adult Patients

6.1.1.Definition, key trends, growth factors, and opportunities, 2021-2031
6.1.2.Market size analysis, by region, 2021-2031
6.1.3.Market share analysis, by country, 2021-2031

6.2.Pediatric Patients

6.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
6.2.2.Market size analysis, by region, 2021-2031
6.2.3.Market share analysis, by country, 2021-2031

6.3.Research Dive Exclusive Insights

6.3.1.Market attractiveness, 2021-2031
6.3.2.Competition heatmap, 2021-2031

7.Airway Management Devices Market Analysis, by End User

7.1.Hospitals

7.1.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.1.2.Market size analysis, by region, 2021-2031
7.1.3.Market share analysis, by country, 2021-2031

7.2.Ambulatory Care

7.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.2.2.Market size analysis, by region, 2021-2031
7.2.3.Market share analysis, by country, 2021-2031

7.3.Home Care

7.3.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.3.2.Market size analysis, by region, 2021-2031
7.3.3.Market share analysis, by country, 2021-2031

7.4.Others

7.4.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.4.2.Market size analysis, by region, 2021-2031
7.4.3.Market share analysis, by country, 2021-2031

7.5.Research Dive Exclusive Insights

7.5.1.Market attractiveness, 2021-2031
7.5.2.Competition heatmap, 2021-2031

8.Airway Management Devices Market, by Region

8.1.North America

8.1.1.U.S.

8.1.1.1.Market size analysis, by Device Type, 2021-2031
8.1.1.2.Market size analysis, by Patient Age, 2021-2031
8.1.1.3.Market size analysis, by End User, 2021-2031

8.1.2.Canada

8.1.2.1.Market size analysis, by Device Type, 2021-2031
8.1.2.2.Market size analysis, by Patient Age, 2021-2031
8.1.2.3.Market size analysis, by End User, 2021-2031

8.1.3.Mexico

8.1.3.1.Market size analysis, by Device Type, 2021-2031
8.1.3.2.Market size analysis, by Patient Age, 2021-2031
8.1.3.3.Market size analysis, by End User, 2021-2031

8.1.4.Research Dive Exclusive Insights

8.1.4.1.Market attractiveness, 2021-2031
8.1.4.2.Competition heatmap, 2021-2031

8.2.Europe

8.2.1.Germany , 2021-2031

8.2.1.1.Market size analysis, by Device Type, 2021-2031
8.2.1.2.Market size analysis, by Patient Age, 2021-2031
8.2.1.3.Market size analysis, by End User, 2021-2031

8.2.2.UK

8.2.2.1.Market size analysis, by Device Type, 2021-2031
8.2.2.2.Market size analysis, by Patient Age, 2021-2031
8.2.2.3.Market size analysis, by End User, 2021-2031

8.2.3.France

8.2.3.1.Market size analysis, by Device Type, 2021-2031
8.2.3.2.Market size analysis, by Patient Age, 2021-2031
8.2.3.3.Market size analysis, by End User, 2021-2031

8.2.4.Spain

8.2.4.1.Market size analysis, by Device Type, 2021-2031
8.2.4.2.Market size analysis, by Patient Age, 2021-2031
8.2.4.3.Market size analysis, by End User, 2021-2031

8.2.5.Italy

8.2.5.1.Market size analysis, by Device Type, 2021-2031
8.2.5.2.Market size analysis, by Patient Age, 2021-2031
8.2.5.3.Market size analysis, by End User, 2021-2031

8.2.6.Rest of Europe

8.2.6.1.Market size analysis, by Device Type, 2021-2031
8.2.6.2.Market size analysis, by Patient Age, 2021-2031
8.2.6.3.Market size analysis, by End User, 2021-2031

8.2.7.Research Dive Exclusive Insights

8.2.7.1.Market attractiveness, 2021-2031
8.2.7.2.Competition heatmap, 2021-2031

8.3.Asia-Pacific

8.3.1.China

8.3.1.1.Market size analysis, by Device Type, 2021-2031
8.3.1.2.Market size analysis, by Patient Age, 2021-2031
8.3.1.3.Market size analysis, by End User, 2021-2031

8.3.2.Japan

8.3.2.1.Market size analysis, by Device Type, 2021-2031
8.3.2.2.Market size analysis, by Patient Age, 2021-2031
8.3.2.3.Market size analysis, by End User, 2021-2031

8.3.3.India

8.3.3.1.Market size analysis, by Device Type, 2021-2031
8.3.3.2.Market size analysis, by Patient Age, 2021-2031
8.3.3.3.Market size analysis, by End User, 2021-2031

8.3.4.Australia

8.3.4.1.Market size analysis, by Device Type, 2021-2031
8.3.4.2.Market size analysis, by Patient Age, 2021-2031
8.3.4.3.Market size analysis, by End User, 2021-2031

8.3.5.South Korea

8.3.5.1.Market size analysis, by Device Type, 2021-2031
8.3.5.2.Market size analysis, by Patient Age, 2021-2031
8.3.5.3.Market size analysis, by End User, 2021-2031

8.3.6.Rest of Asia-Pacific

8.3.6.1.Market size analysis, by Device Type, 2021-2031
8.3.6.2.Market size analysis, by Patient Age, 2021-2031
8.3.6.3.Market size analysis, by End User, 2021-2031

8.3.7.Research Dive Exclusive Insights

8.3.7.1.Market attractiveness, 2021-2031
8.3.7.2.Competition heatmap, 2021-2031

8.4.LAMEA

8.4.1.Brazil

8.4.1.1.Market size analysis, by Device Type, 2021-2031
8.4.1.2.Market size analysis, by Patient Age, 2021-2031
8.4.1.3.Market size analysis, by End User, 2021-2031

8.4.2.Saudi Arabia

8.4.2.1.Market size analysis, by Device Type, 2021-2031
8.4.2.2.Market size analysis, by Patient Age, 2021-2031
8.4.2.3.Market size analysis, by End User, 2021-2031

8.4.3.UAE

8.4.3.1.Market size analysis, by Device Type, 2021-2031
8.4.3.2.Market size analysis, by Patient Age, 2021-2031
8.4.3.3.Market size analysis, by End User, 2021-2031

8.4.4.South Africa

8.4.4.1.Market size analysis, by Device Type, 2021-2031
8.4.4.2.Market size analysis, by Patient Age, 2021-2031
8.4.4.3.Market size analysis, by End User, 2021-2031

8.4.5.Rest of LAMEA

8.4.5.1.Market size analysis, by Device Type, 2021-2031
8.4.5.2.Market size analysis, by Patient Age, 2021-2031
8.4.5.3.Market size analysis, by End User, 2021-2031

8.4.6.Research Dive Exclusive Insights

8.4.6.1.Market attractiveness, 2021-2031
8.4.6.2.Competition heatmap, 2021-2031

9.Competitive Landscape

9.1.Top winning strategies, 2021

9.1.1.By strategy
9.1.2.By year

9.2.Strategic overview

9.3.Market share analysis, 2021

10.Company Profiles

10.1. Medtronic

10.1.1.Overview
10.1.2.Business segments
10.1.3.Product portfolio
10.1.4.Financial performance
10.1.5.Recent developments
10.1.6.SWOT analysis

10.2.Smiths Medical, Inc.

10.2.1.Overview
10.2.2.Business segments
10.2.3.Product portfolio
10.2.4.Financial performance
10.2.5.Recent developments
10.2.6.SWOT analysis

10.3.Teleflex Incorporated.

10.3.1.Overview
10.3.2.Business segments
10.3.3.Product portfolio
10.3.4.Financial performance
10.3.5.Recent developments
10.3.6.SWOT analysis

10.4. KARL STORZ SE & Co. KG

10.4.1.Overview
10.4.2.Business segments
10.4.3.Product portfolio
10.4.4.Financial performance
10.4.5.Recent developments
10.4.6.SWOT analysis

10.5.Ambu A/S.

10.5.1.Overview
10.5.2.Business segments
10.5.3.Product portfolio
10.5.4.Financial performance
10.5.5.Recent developments
10.5.6.SWOT analysis

10.6.Flexicare (Group) Limited

10.6.1.Overview
10.6.2.Business segments
10.6.3.Product portfolio
10.6.4.Financial performance
10.6.5.Recent developments
10.6.6.SWOT analysis

10.7.Intersurgical Ltd

10.7.1.Overview
10.7.2.Business segments
10.7.3.Product portfolio
10.7.4.Financial performance
10.7.5.Recent developments
10.7.6.SWOT analysis

10.8.SunMed

10.8.1.Overview
10.8.2.Business segments
10.8.3.Product portfolio
10.8.4.Financial performance
10.8.5.Recent developments
10.8.6.SWOT analysis

10.9.VYAIRE MEDICAL, INC.

10.9.1.Overview
10.9.2.Business segments
10.9.3.Product portfolio
10.9.4.Financial performance
10.9.5.Recent developments
10.9.6.SWOT analysis

10.10.Vbm Medizintechnik.

10.10.1.Overview
10.10.2.Business segments
10.10.3.Product portfolio
10.10.4.Financial performance
10.10.5.Recent developments
10.10.6.SWOT analysis

11.Appendix

11.1.Parent & peer market analysis
11.2.Premium insights from industry experts
11.3.Related reports



★調査レポート[世界の気道管理デバイス市場2022年-2031年：デバイス種類別（声門下デバイス、声門上デバイス、喉頭鏡、蘇生器、その他）、患者年齢別（成人患者、小児患者）、エンドユーザー別（病院、外来治療、在宅ケア、その他）] (コード：RDV23MA012)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の気道管理デバイス市場2022年-2031年：デバイス種類別（声門下デバイス、声門上デバイス、喉頭鏡、蘇生器、その他）、患者年齢別（成人患者、小児患者）、エンドユーザー別（病院、外来治療、在宅ケア、その他）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の気道管理装置市場2021-2031：種類別（声門下装置、声門上装置、喉頭鏡、蘇生器、その他）、患者年齢別、エンドユーザー別
  • 世界のワイヤレス脳センサー市場2022年-2031年：製品種類別（脳波計（EEG）デバイス、睡眠モニタリングデバイス、脳磁図（MEG）デバイス、その他）、用途別（アルツハイマー病、外傷性脳損傷、てんかん、睡眠障害、その他）、エンドユーザー別（病院、研究、学術機関/研究所、在宅ケア、その他）
  • 世界の拡張現実（AR）市場2022年-2031年：コンポーネント別（ハードウェア、ソフトウェア）、デバイス種類別（ヘッドマウントディスプレイ、ハンドヘルドデバイス、その他）、最終用途別（メディア＆エンターテイメント、製造＆建設、医療、教育、小売、その他）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）
  • 世界の気道管理デバイス市場2022-2029：種類別（声門下気道管理デバイス、声門上気道管理デバイス、蘇生器、喉頭鏡、その他）、用途別、エンドユーザー別、患者年齢別、地域別
  • 世界の気道管理デバイス市場2022-2029：種類別（声門下気道管理デバイス、声門上気道管理デバイス、蘇生器、喉頭鏡、その他）、用途別、エンドユーザー別、患者年齢別、地域別
  • 世界のバリアシステム市場2021年-2031年：デバイス種類別（フェンス、ボラード、ゲート、衝突防止システム、ドロップアーム）、技術別、材質別、用途別
  • 世界のウェアラブル決済デバイス市場2021年-2031年：デバイス種類別（フィットネストラッカー、スマートウォッチ、決済リストバンド、スマートリング）、技術別（NFC、RFID、QR＆バーコード）、用途別（小売＆食料品店、娯楽施設、レストラン＆バー、病院＆薬局）
  • 世界のマルチパラメータ患者モニタリングシステム市場（～2030年）：デバイス種類別（固定型、ポータブル型）、強度レベル別（高、中、低）、年齢層別（小児、成人、高齢者）、エンドユーザー別（病院、在宅医療施設、外来手術センター）
  • 世界のレフサム病治療市場2023-2033：種類別（手術、投薬）、エンドユーザー別（病院、クリニック、研究センター、在宅ケア）、患者年齢層別（小児、成人）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆